✦ LIBER ✦

Intraperitoneal radioimmunotherapy of refractory ovarian carcinoma utilizing iodine-131-labeled monoclonal antibody OC125

✍ Scribed by Michael G. Muto; Neil J. Finkler; Amin I. Kassis; Anthony E. Howes; Lisa L. Anderson; Ching C. Lau; Vincent R. Zurawski Jr.; Kevin Weadock; Sabah S. Tumeh; Phillip Lavin; Robert C. Knapp

Book ID: 119054202
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 875 KB
Volume: 45
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(92)90302-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radioimmunoscintigraphy of ovarian cance

Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments

✍ Georg Barzen; Anton Carl Mayr; Mathias Langer; Rolf Becker; Michael Cordes; Chri 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 649 KB

In vitro cytotoxicity of 131I-labeled mo

In vitro cytotoxicity of 131I-labeled monoclonal antibody OC125 F(ab)2 on epithelial ovarian cancer cell lines

✍ E.S. Gadicke; C. Lau; R. Macklis; N. Finkler; R. Knapp 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Biodistribution study of radiolabeled mo

Biodistribution study of radiolabeled monoclonal antibody OC 125 in a nude mouse model intraperitoneally grafted with a human ovarian carcinoma

✍ Thedrez, Philippe; Kremer, Mireille; Curtet, Chantal; Sai, Catherine; Guerreau, 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 112 KB

Evaluation of therapeutic response using

Evaluation of therapeutic response using iodine-131-B72.3 monoclonal antibody in patients with ovarian carcinoma

✍ L. Camera; S. Vecchio; A. Petrillo; G. Esposito; G. Frasci; R. V. Iaffaioli; A. 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 755 KB

We used radiolabelled monoclonal antibodies (MoAbs) to prove disease persistence after treatment for ovarian carcinoma. Twelve patients with histologically confirmed ovarian carcinoma were studied. They received 5 mCi (1 mg) of iodine-131-B72.3 by intravenous injection before and after a complete co

Single-dose intraperitoneal radioimmunot

Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: Clinical results in patients with minimal residual disease of ovarian cancer

✍ F. Crippa; G. Bolis; E. Seregni; N. Gavoni; G. Scarfone; C. Ferraris; G.L. Burag 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 621 KB